Younger adult endometrial cancer survivors with short-term exposure to vaginal estrogen therapy (ET) do not have an elevated ...

More than 44,000 Australian women are expected to be diagnosed with uterine cancer in the next decade, but more than half of ...

A CAR-NKT cell therapy targets cancer through multiple pathways, showing complete tumor elimination in preclinical models. The off-the-shelf platform reduces costs, improves access, and the therapy ...

Women who previously had endometrial cancer and used vaginal estrogen therapy did not have higher risk for cancer recurrence ...

Women who use vaginal estrogen to manage early menopause after treatment for endometrial cancer may not have an increased ...

ACR-368, a CHK1/2 inhibitor in a registrational-intent Phase 2b study, showed potent preclinical synergy with Topoisomerase 1 (Topo 1) ...

Despite the increased incidence of endometrial cancer in younger women, there is limited research regarding the safety of local, low-dose vaginal estrogen therapy (ET) for survivors. A new study ...

While women tend to be most concerned with cancers such as breast, colorectal, and endometrial, thyroid cancer should be on ...

In January, the American Cancer Society reported that for the first time women younger than 50 had a higher cancer incidence rate than men. Based on 2023 data, cancer incidence rates among women under ...